nVerses Capital’s Acadia Healthcare ACHC Stock Holding History

nVerses Capital’s Portfolio ACHC Stock Details ACHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,400	Closed	-$94.6K	–	962
2024 Q2	$94.6K	Buy	+1,400	New	+$97.8K	0.06%	456

Other funds holding ACHC

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

nVerses Capital's ACHC Position: Q3 2024 in Review

nVerses Capital sold out of Acadia Healthcare (ACHC) in Q3 2024, closing a stake of 1,400 shares — an estimated $94.6K sold.

nVerses Capital first reported a position in ACHC in Q2 2024 and held it in 1 quarter. The position peaked at $94.6K in Q2 2024. 312 funds tracked by Wall St. Rank hold ACHC as of Q3 2024.

nVerses Capital reported no remaining Acadia Healthcare position as of Q3 2024 after selling out during the quarter.
nVerses Capital sold 1,400 Acadia Healthcare shares in Q3 2024, an estimated $94.6K.
nVerses Capital first reported a position in Acadia Healthcare in Q2 2024 and held it in 1 quarter.
nVerses Capital's Acadia Healthcare position peaked at $94.6K in Q2 2024.
312 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2024.

Based on nVerses Capital's 13F filing for Q3 2024, filed 16 Oct 2024.